-
I - What we study
-
Located in
Labs
/
Metalloproteins and Bioenergetics Unit
-
iBET is the new member of ACTIP
-
Being part of ACTIP is a major opportunity to leverage competences in Animal Cell Technology to a superior level
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
IBET on SpeCCC project
-
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
iBET participates in CARDIOPATCH Scientific Meeting
-
The first annual meeting of the CARDIOPATCH consortium took place on the 21st of October in Toulouse
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
iBET researchers interviewed on viral-based vaccines
-
Conversation about current challenges and benefits of process intensification of viral-based vaccines
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
iBET, AbbVie and IPO team-up to improve predictivity of ex-vivo tumour models
-
Development of innovative and predictive 3D cell models for solid tumors
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
iBET’s expertise in vaccine development presented to Health Authorities
-
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
Identification of cell wall-specific targets for antimicrobials against Staphylococcus epidermidis pathogenic strains
-
Located in
Education
/
Master Courses
/
Master Research Projects
-
IMI-EU funding to accelerate Advanced Therapy Medicinal Products
-
iBET participates in ARDAT – Accelerating Research and Innovation for Advanced Therapies project which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs)
Located in
Labs
/
Animal Cell Technology Unit
/
Press Releases
-
Improving a biological hydrogen machine
-
Development of hydrogenase variants with improved properties reveals new pathways of oxygen inactivation
Located in
News
